Boehringer Ingelheim Email Format
Pharmaceutical Manufacturing
・
50,001-100,000 employees
・
Ingelheim am Rhein, Germany
Boehringer Ingelheim is a global pharmaceutical company that researches, develops, and manufactures innovative medicines and therapies for human and animal health.
Search our verified sources for decision-makers, emails, and titles.
Start searching
VERIFIED BY CLAY
first.last@boehringer-ingelheim.com
Company Overview
Industry
Pharmaceutical Manufacturing
Founded
1885
Headquarters
Ingelheim am Rhein, Germany
Revenue
$5B-$10B
FUNDING Stage
Family-Owned
Key Executives
Shashank Deshpande (Chairman of the Board of Managing Directors), Frank Hubler (Member of the Board of Managing Directors with responsibility for Finance), Harsha Deshmukh (Member of the Board of Managing Directors with responsibility for IT and Global Business Services)
Tech Stack
Key Executives
4.9/5 on G2
40K+ GTM professionals
SOC 2 Type II certified
Frequently Asked Questions
What is the email format of Boehringer Ingelheim?
Boehringer Ingelheim uses the first.last format, so Jane Smith would be jane.smith@boehringer-ingelheim.com.
What are the two main business segments at Boehringer Ingelheim?
Boehringer Ingelheim operates through two primary business segments: Human Pharma and Animal Health. In 2025, Human Pharma generated EUR 22.7 billion in net sales while Animal Health contributed EUR 4.9 billion, together reaching EUR 27.8 billion in total group net sales.
Which therapeutic areas does Boehringer Ingelheim focus on in its Human Pharma pipeline?
Boehringer Ingelheim concentrates its Human Pharma research on cardiovascular, renal and metabolic diseases, oncology, respiratory and immunology, mental health, and eye health. Key marketed products include JARDIANCE for type 2 diabetes and heart failure, and OFEV for pulmonary fibrosis.
Who chairs the Board of Managing Directors at Boehringer Ingelheim in 2026?
Shashank Deshpande serves as Chairman of the Board of Managing Directors at Boehringer Ingelheim in 2026, also holding responsibility for the Human Pharma Business Unit. He assumed the chairmanship on 1 July 2025.
How can I find a verified contact email at Boehringer Ingelheim for outreach?
Since Boehringer Ingelheim follows the first.last@boehringer-ingelheim.com format, you can construct emails directly once you have a contact name. Tools like Clay can help you verify these addresses and enrich prospect lists with accurate Boehringer Ingelheim contact data at scale.
Get access to more people and company data using Clay
Leverage the power of 100+ data providers for industry-leading data coverage & quality.
4.9 rating